Trial Profile
The Application of Overactive Bladder Symptom Score (OABSS) in Response to Treatment in Chinese Population
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Apr 2016
Price :
$35
*
At a glance
- Drugs Solifenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 01 Jan 2014 Status changed from recruiting to completed according to results published in the Chinese Medical Journal.
- 23 May 2012 New trial record